-
 No real news
-
 AMA approves of Marijuana
Cannabis Science Hails The American Medical Association For Urging The United States To Facilitate Clinical Research and Development of Cannabinoid-Based Medicines...Font size: A | A | A3:16 PM ET 11/16/09 | BusinessWire
Cannabis Science Hails The American Medical Association For Urging The United States To Facilitate Clinical Research and Development of Cannabinoid-Based Medicines Which Validates The Company's Strategy To Produce Critically Important FDA Approved Cannabinoid-Based Medicines For Patients
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is hailing the call by the American Medical Association's House of Delegates for "marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines."
Richard Cowan, Cannabis Science CFO, noted, "The AMA has officially joined the other medical groups in their recognition of the medical value of cannabis. Last year, the American College of Physicians also called for a reclassification of cannabis' Schedule I status. Previously, many other health organizations, including the American Nurses Association and the American Public Health Association, have called for the legal recognition of medical cannabis."
Under federal law, all substances in Schedule I are defined as possessing "no currently accepted use in treatment in the United States" and also having a high potential for abuse. In 1970 Congress classified marijuana, and all of the cannabinoids (even those with no psychoactive properties) as Schedule I substances upon passage of the Controlled Substances Act. This classification was supposed to be temporary, but blocking research kept it in Schedule I.
Dr. Robert Melamede, PhD., Cannabis Science Inc. President and CEO, stated, "It is now clear that the AMA has embraced the plethora of peer reviewed science supporting the medical applications of the cannabis plant. Their call for the US to facilitate 'research and development of cannabinoid-based medicines' is an important validation of our company's strategy and should make it much easier for us to develop and market products that will help patients. Most people would be shocked to know that the federal government has actually been blocking research on the medical benefits of cannabis while supporting research aimed at demonstrating the negatives. Now that the AMA has embraced this modern science, and President Obama has created new Federal policies and guidelines, the Federal Government can no longer ignore the importance of cannabinoid-based medicines."
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
SOURCE: Cannabis Science Inc.
View data
Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
info@cannabisscience.com
Introducing...
or
Peter Glaser, 1-888-889-0888
Investor Relations
info@cannabisscience.com
Introducing...
Cannabis Science Inc. Dr. Robert J. Melamede, 1-888-889-0888 President & CEO info@cannabisscience.com Introducing... or Peter Glaser, 1-888-889-0888 Investor Relations info@cannabisscience.com Introducing...
-
 The H1N1 Scam - A prisoner's perspective
By David Malmo-Levine, Cannabis Culture - Thursday, December 17 2009
CANNABIS CULTURE - Herbs not vaccines! Imprisoned pot activist David Malmo-Levine says the H1N1 vaccine may be more dangerous than the virus itself.
[Editor's Note: David Malmo-Levine is currently serving a six-month prison sentence in British Columbia for his unique form of cannabis activism. Click here and here to read more about David's case. Read more from David on his CC blog.]
This was going to be a more thoroughly researched article but the research material my editor Jeremiah tried to drop off for me at Fraser Regional Correctional Center was turned away. Something about its sheer volume overwhelming them, as if I was going to roll all those bits of paper up and smash my window out.
Maybe they were interested in keeping prisoners ignorant in general...or ignorant about H1N1 in particular.
There was a good article on page C5 of the November 28th Vancouver Sun, written by Christopher Shaw about the H1N1 flu and the vaccine. Apparently the H1N1 flu isn't nearly as deadly as the average seasonal flu, while there are good reasons to doubt the safety of the vaccine.
Many newspaper articles that report the number of deaths from H1N1 don't report the comparative number of deaths from the regular flu. Adding to this hype in the media are the full page advertisements: page A17 of the November 6 Province details the chief public officers "Plan for Canadians", an H1N1 "immunization campaign" the "largest and quickest" in Canadian history. In Fraser Regional Correctional Center there are posters everywhere advising prisoners to get vaccinated. They even dropped off H1N1 preparedness guides encouraging vaccination. Check out the website, at www.fightflu.ca.
When I first arrived at North Fraser, they asked me why I didn't want the shot; I told them I didn't trust it. They responded with the classic appeal to authority, "So you think you know better then the Center for Disease Control, eh?" I responded with: "I know about the Swine Flu vaccination of 1976 where one person died of the flu and 25 people died of the vaccine, and over 1000 ended up with a horrible vaccine-related diseases."
Swine Flu 1976 & Propaganda
The North Fraser doctor had no response to that. When I was moved from North Fraser to Fraser Regional it was at the height of the scare. The nurses were busy taking each prisoner's temperature. When it came time for my turn, I asked one of them, "Isn't true that at the Nuremberg Doctors' Trial a precedent was established that medical procedures could not be conducted without the consent of the patient? "I'd agree with that," responded the nurse, adding, "unless there were extenuating circumstances." They didn't elaborate.
I suspected those circumstances had something to do with the various mandatory vaccination programs in Canada and the United States over the years. Funny how both the Nazis and representative democracies used terrorism as a boogieman to justify the removal of the medical autonomy of the individual.
If you are worried about protection from flu bugs, there are several less-dangerous alternatives to the H1N1 vaccination - some you might not have expected.
Dr. Robert J. Melamede, Director and Chief Science Officer of Cannabis Science Inc. says cannabis should be taken seriously as a means of combating H1N1 and other flu viruses.
"The high lethality of some strains of flu can be attributed to the excessive inflammatory response driven by Tumor Necrosis Factor (TNF)," Melamede said. "Endocannabinoids are nature's way of controlling TNF activity. Phytocannabinoids can mimic the natural endocannabinoids to prevent excessive inflammatory immune responses."Emphasis added by 420investor
This seems feasible, though I think it needs more research. Unfortunately, getting medical marijuana in jail is simply not an option. Instead, I repeatedly asked Dr. Beckett, the doctor here at Fraser, for permission to get a bottle of grapefruit seed extract. For years I have been using it to keep colds, flus, and sore throats away. Whenever I would feel a scratchy throat or fever coming on, I would just dose myself with GSE and 10 minutes later I would feel better. It worked on all my friends too, at least the ones that could handle the horrible taste.
Dr. Beckett told me he had read studies that proved grapefruit seed extract was unsafe when mixed with some other drugs and was not effective, and that even though I wasn't taking any other drugs he could not take the chance. I asked him the names of the studies and he declined to provide them. I often hear similar references to nameless unprovided studies when speaking to anti-pot doctors about cannabis. I think it's a pat answer they all learn in med-school. I'm almost certain grapefruit seed extract comes out safer and more effective than vaccinations when comparing safety, efficacy and cost, just as I'm almost certain that GSE is not studied as much as it should be because it can't be patented and vaccines are not studied as much as they should be because corporations have invested billions into them and have no desire to learn about the long term side effects.
Speaking about those side effects, I came across an article on page A11 of the November 18 Province entitled, "36 Serious Reactions to Vaccine Among 6.6 Million Shots".
Canada's Chief Public Health Officer David Butler Jones was quoted as saying that the serious adverse effects are rare and that the "benefits of vaccination outweigh any theoretical risks." Where was this guy during the 1976 swine flu fiasco? And for how long do they monitor shot recipients? Nowhere in any media have I seen statistics on how many flu victims have gone on to get the flu despite getting the vaccine. The Center for Disease Control's website lists short-term side effects of the vaccine including fever, aches, sore throat, cough and others - all indistinguishable from symptoms of the virus itself.
As it turns out, the only prisoner quarantined in my unit had received a shot before he caught swine flu. I've been fighting back a scratchy throat using a combination of orange juice, vitamins, Fisherman's Friends, and chewing on orange seeds. Interestingly, the only contraband I've seen confiscated so far was a prisoner's stash of oranges.
Another topic that has been missing from the newspapers is the suspicious origin of the H1N1. Apparently it is a mixture of four different flu strains (more here under "Genetics") from four different parts of the world, nearly impossible to recombine naturally but fairly easy to recombine in a lab. This despite being the topic of many Hollywood films including "Outbreak", "The Hulk", and "Aliens", all of which have been repeatedly playing on the movie channels here - not to mention "V for Vendetta".
The concept of biological war profiteering is still taboo in the major news media. The Baxter Corporation patented the H1N1 vaccine a year before the outbreak and apparently the same corporation accidentally mixed the H1N1 strain with a more deadly strain. I wonder what affect that would have had on sales had it not been caught just in time. According to research I collected for my magazine PotShot #19, similar conflicts of interest are associated with anthrax, West Nile, small pox and AIDS vaccines. There should be a serious investigation into these conflicts of interest, especially the anthrax attack of 2001, which was blamed on a rogue, crazy scientist when it was Bayer, makers of Cipro and weaponized anthrax, who should have been investigated.
I fear, with good reason, that a future biological terrorist attack could be results of another corporation hoping to make another killing from selling another cure to another disease they have access to.
If you wish to look at the materials that were too dangerous to send to me at Fraser Regional click here.
Last edited by 420investor; 01-11-2010 at 10:41 AM.
-
VERY SOLID ACTION THIS WEEK
CBIS -- great day, solid action -- awesome news & coverage this week
chart is turned back up and looking strong http://stockcharts.com/h-sc/ui?s=cbis
Cannabis Science Inc. (CBIS) Announces Progress in Bringing the First Cannabis Based Medicine to Market Company moving towards contracts and licensing agreements for research and development of new medicines
http://finance.yahoo.com/news/Cannab....html?x=0&.v=1
added coverage out -- http://www.quote.com/news/story.action?id=MTO041u7845
start some dd -- http://ddmachine.com/default.asp?s=cbis
yahoo link -- http://finance.yahoo.com/q?s=CBIS.OB
web site -- http://www.cannabisscience.com/
Executive Offices
Cannabis Science Inc
6946 N Academy Blvd
Suite B #254
Colorado Springs, CO 80918
Email: info@cannabisscience.com
Telephone: 1.888.889.0888
Fax: 1.866.943.5085
-
(CBIS) Announces Progress in Bringing the First Cannabis Based Medicine to Market
Here's the PR recently released, for those of you doubting the business check out GW Pharmaceuticals listed as GWP in London Exchange, GW currently licenses Sativex a cannabis based spray and they have major contracts with that product in place. CBIS is looking to something similar in the United States.
Cannabis Science Inc. (NASD OTCBB: CBIS), a pharmaceutical cannabis company in the US, is pleased to announce it is finalizing agreements with suppliers, manufactures, and research institutions that it expects will close within days and weeks to come. Once these agreements are closed they will be announced along with details on how CBIS will bring its first Cannabis based pharmaceutical products to market.
“We have worked hard to get to this point and look forward to sharing the details with our shareholders in a timely fashion, and we appreciate their continued support” stated Dr. Robert Melamede, President & CEO.
Cannabis Science is in negotiations with several companies in the US and internationally to contract or license its cannabis based formulations for development, certain rights to manufacturing processes, and sales in each prospective jurisdiction and or country.
-
 ****FLASH ALERT ISSUED****
2010 Best Picks Alert Issued.... 12-Feb-10 12:33 pm
News flash 12.33pm Feb 12 2010 Access Financial Group, picks five canadian stocks that have the ability to at least double with up to a ten bagger in 2010.
The list is as follows
Breakwater Resources BWR-T - price today .395 target price .80
Wallbridge Mining WM-T - price today .295 target price .90
Ursa Major UMJ-T - price today .11 target price .50
United Reef URP-V price today .03 target price .25
Rubicon Minerials RMX-T price today 4.43 target price 8.60.
The above companies should do very well in 2010 conditions..
Sentiment : Strong Buy Must Own Further Upside In The Weeks Ahead.
-
CBIS issues Promising News
“The only interesting answers are those which destroy the questions.”
Sometimes I promote Stocks, Sometimes I dont
-
CBIS always in the headlines.
with that early morning release CBIS gapped up at the open of the market giving them a price of .11 cents at open. and hit a high of .125 cents so far today. now its had a pullback down to .11 cents.
http://biz.yahoo.com/pz/100628/195188.html?.v=1
-
CBIS half off
.10 they should be back to .20 this is half off with this news out
-
Cannabis Science Reports Important Validation for Medical Cannabis as Bayer Pays '$15 Million Milestone Payment' for GW Pharmaceuticals' Sativex(R) for MS, as the UK Government Approves "First Prescription Cannabis Medicine"
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Reply With Quote
Posting Permissions
Bookmarks